Why Is DENTSPLY SIRONA INC (XRAY) Stock Down Today?

Dentsply Sirona Inc. (XRAY) fell 8.05% to $12.11 in morning trading on Tuesday. The sharp decline followed the release of its Q2 2026 earnings report and a subsequent 8-K filing on August 7. While the company beat revenue and earnings estimates and reaffirmed its full-year guidance, the stock opened with a -1.3% gap down and quickly declined further amid heavy early trading volume.

What Happened

The stock opened at $13.00, below the prior close of $13.17, and fell to a session low of $12.01 within the first hour of trading. The Q2 earnings report showed adjusted earnings per share of $0.52, surpassing the $0.35 consensus estimate, while revenue came in at $898 million, beating the $889.81 million estimate. The company also reaffirmed its full-year 2026 guidance for adjusted earnings per share of $1.40 to $1.50 and revenue of $3.5 billion to $3.6 billion. Despite these positive results, the stock declined sharply, suggesting market skepticism or a reassessment of the company’s growth trajectory.

The 8-K filing on August 7 provided additional details on the company’s financial results and included financial statements and exhibits. The filing did not indicate any material negative developments. Analysts from Baird and BMO Capital recently raised their price targets for the stock, but the market reacted negatively on Tuesday.

What The Data Shows

The stock traded at a session high of $13.58 at market open before declining sharply. Volume of 1.4 million shares was 0.3 times the 3-month daily average, indicating unusual activity for a stock with a market cap of $2.8 billion. The stock is currently trading near its 52-week low of $9.40, down from a high of $14.86. The company has a negative trailing twelve-month earnings per share of -$3.15 and a net margin of -17.1%. Recent insider transactions show six buys totaling $617,000 in the last 90 days, with no sales reported.

What To Watch

The stock is set to continue trading in the afternoon session. Investors should monitor the company’s ability to meet its full-year guidance and the broader market reaction to its return-to-growth investments. Coverage of the earnings report is expected to expand in the coming days.